She demonstrated that metastatic tumor cells engage in reciprocal interactions with bone marrow adipocytes to evade therapy and provided evidence that targeting IL-1β or lipolysis improves tumor cell response to anti-cancer therapy with docetaxel (26). The gene discussed is IL1B; the disease is neoplasm.